𝔖 Bobbio Scriptorium

✦ LIBER ✦

The anti-ischemic potential of angiotensin-converting enzyme inhibition: Insights from the heart outcomes prevention evaluation trial

✍ Scribed by Bertram Pitt

Book ID: 112065399
Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 692 KB
Volume: 23
Category: Article
ISSN: 0160-9289
DOI: 10.1002/clc.4960230704

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Benefit of bolus-only platelet glycoprot

Benefit of bolus-only platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: Insights from the very early outcomes in the Evaluation of 7E3 for the Prevention of Ischemic Complications (EPIC) trial

✍ Jonathan D. Marmur; Cristina A. Mitre; Elliot Barnathan; Erdal Cavusoglu 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 126 KB

Renal Outcomes in High-Risk Hypertensive

Renal Outcomes in High-Risk Hypertensive Patients Treated With an Angiotensin-Converting Enzyme Inhibitor or a Calcium Channel Blocker vs. a Diuretic. A Report From the Antihypertensive and Lipid-lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

✍ M. Rahman; S. Pressel; B.R. Davis 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 40 KB

In women with symptoms of cardiac ischem

In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE)

✍ Daniel F. Pauly; B. Delia Johnson; R. David Anderson; Eileen M. Handberg; Karen 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 250 KB